GeoffreyKimMD

Oncology • Bethesda, MD

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
National Cancer Institute
10 Center Drive Building 10
Bethesda, MD 20892
Phone+1 301-496-4916

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
New York Medical CollegeClass of 2004

Certifications & Licensure

MD State Medical License 2007 - 2026

Publications & Presentations

PubMed

225 citations
Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms
Paul G. Kluetz, Ashley F. Slagle, Elektra J. Papadopoulos, Laura Lee Johnson, Martha Donoghue
Clinical Cancer Research. 2016-04-01
48 citations
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Ad...
Gwynn Ison, Julia A. Beaver, W. David McGuinn, Todd R. Palmby, Jeannette Dinin
Clinical Cancer Research. 2016-09-15
104 citations
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation–Associated Advanced Ovarian Cancer
Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton, Laura L. Fernandes, Shenghui Tang
Clinical Cancer Research. 2017-12-01